Renasant Bio (Renasant), announced its launch today to advance next-generation disease-modifying treatments for autosomal dominant polycystic kidney disease (ADPKD), the leading genetic cause of ...

Dispatch Bio has unveiled with $216 million and the lofty goal of creating a universal treatment for solid tumors using a new immunotherapy approach. | Dispatch Bio has unveiled with $216 million and ...

The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of ...

Startups like Ovasave are hoping to ride that wave by addressing long-standing taboos and gaps in care, particularly in ...

Weigh the pros and cons of at-home treatment before making the investment Just 2" beneath the soil lies the pea-sized keys to your future—seeds. Many farmers are turning to seed treatments to ...

AgReliant and GDM join forces. Beck’s buys Syngenta facility in Nebraska. New opportunities abound for canola growers.

For decades, agriculture has been one of the major drivers of Nigeria’s economy, employing nearly 70 percent of the rural ...

N-trans-caffeoyltyramine (NCT) is a natural bioactive compound attracting considerable interest from researchers for its potential role in healthy liver fat metabolism, gut barrier function, and mitoc ...

The best new products of the month include e.l.f. Cosmetics' free color-analysis tool, OLLY's first foray into bodycare and a ...

A robotic root-sensing system developed at The University of Queensland is opening up new opportunities for more productive agricultural crops. ..Read More ...

The trio was tasked with setting the rivalry to rest. Is Iowa the ultimate state fair 'Field of Dreams' or does its neighbor hold (purple) reign?

Dr Jordan Lane, Chief Scientific Officer at Ignota Labs, has been appointed Industry and Enterprise Fellow of Clare Hall, Cambridge, for his extensive experience in the AI drug discovery space.